AGM/EGMAug 7, 2026, 03:43 PM
Nymox to Hold Special Shareholder Meeting for Director Election
AI Summary
Nymox Pharmaceutical Corporation announced a Special Shareholder's Meeting to be held virtually on August 28, 2026, for the election of its Board of Directors. The company also disclosed that its annual report on Form 20-F for the financial year ended December 31, 2025, has been delayed due to previously reported changes in Management and the Board. Shareholders are invited to attend the meeting, with proxy materials provided for voting.
Key Highlights
- Special Shareholder's Meeting scheduled for August 28, 2026, at 4:30 p.m. EDT.
- Meeting purpose is the election of the Company's Board of Directors.
- Management Proxy Circular and related materials are provided for the meeting.
- Nymox's 2025 annual report (Form 20-F) is delayed due to management and Board changes.
- Proxy submission deadline is August 26, 2026, by 5:00 p.m. EDT.
- Record Date for voting eligibility is August 4, 2026.
- Proposed to elect five directors; current board has two members.
- Paul Averback, CEO, President, and Chairman, holds 40.7% of voting securities.
Price Impact